BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BMY - US1101221083 - Common Stock
39.635 EUR
+1.23 (+3.22%)
Overall 1BMY gets a fundamental rating of 6 out of 10. We evaluated 1BMY against 54 industry peers in the Pharmaceuticals industry. 1BMY has only an average score on both its financial health and profitability. 1BMY may be a bit undervalued, certainly considering the very reasonable score on growth Finally 1BMY also has an excellent dividend rating. With these ratings, 1BMY could be worth investigating further for value and dividend investing!.
1. Profitability
1.1 Basic Checks
1BMY had positive earnings in the past year.
1BMY had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1BMY reported negative net income in multiple years.
In the past 5 years 1BMY always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 6.23%, 1BMY perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
1BMY has a better Return On Equity (32.55%) than 80.00% of its industry peers.
With an excellent Return On Invested Capital value of 17.49%, 1BMY belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1BMY is below the industry average of 13.89%.
The 3 year average ROIC (11.67%) for 1BMY is below the current ROIC(17.49%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 17.49% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1.3 Margins
1BMY's Profit Margin of 12.57% is in line compared to the rest of the industry. 1BMY outperforms 52.73% of its industry peers.
1BMY has a Operating Margin of 33.51%. This is amongst the best in the industry. 1BMY outperforms 81.82% of its industry peers.
1BMY's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 73.15%, 1BMY is in line with its industry, outperforming 60.00% of the companies in the same industry.
1BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
1BMY has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1BMY has less shares outstanding
The debt/assets ratio for 1BMY is higher compared to a year ago.
2.2 Solvency
1BMY has an Altman-Z score of 2.10. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1BMY (2.10) is worse than 60.00% of its industry peers.
The Debt to FCF ratio of 1BMY is 3.20, which is a good value as it means it would take 1BMY, 3.20 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.20, 1BMY is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
1BMY has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of 1BMY (2.41) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.1 |
ROIC/WACC2.11
WACC8.3%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1BMY should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, 1BMY is doing worse than 65.45% of the companies in the same industry.
1BMY has a Quick Ratio of 1.17. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
1BMY's Quick ratio of 1.17 is fine compared to the rest of the industry. 1BMY outperforms 65.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 460.68%, which is quite impressive.
1BMY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.57% yearly.
Looking at the last year, 1BMY shows a small growth in Revenue. The Revenue has grown by 1.26% in the last year.
Measured over the past years, 1BMY shows a quite strong growth in Revenue. The Revenue has been growing by 13.06% on average per year.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
3.2 Future
1BMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.26% yearly.
Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -4.97% on average per year.
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
1BMY is valuated cheaply with a Price/Earnings ratio of 7.04.
94.55% of the companies in the same industry are more expensive than 1BMY, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 1BMY to the average of the S&P500 Index (26.59), we can say 1BMY is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.57, the valuation of 1BMY can be described as very cheap.
90.91% of the companies in the same industry are more expensive than 1BMY, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of 1BMY to the average of the S&P500 Index (23.80), we can say 1BMY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.04 | ||
| Fwd PE | 7.57 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 92.73% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than 1BMY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.14 | ||
| EV/EBITDA | 5.97 |
4.3 Compensation for Growth
1BMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1BMY's earnings are expected to grow with 73.98% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y131.22%
EPS Next 3Y73.98%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.77%, 1BMY is a good candidate for dividend investing.
1BMY's Dividend Yield is rather good when compared to the industry average which is at 2.90. 1BMY pays more dividend than 90.91% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, 1BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
5.2 History
The dividend of 1BMY is nicely growing with an annual growth rate of 11.67%!
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
82.81% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
The dividend of 1BMY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP82.81%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
BIT:1BMY (11/20/2025, 7:00:00 PM)
39.635
+1.23 (+3.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners81.74%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap80.69B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts67.65
Price Target45.28 (14.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
Yearly Dividend2.07
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)2.04%
PT rev (3m)-2%
EPS NQ rev (1m)5.31%
EPS NQ rev (3m)4.49%
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)2.19%
Revenue NY rev (1m)1.32%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.04 | ||
| Fwd PE | 7.57 | ||
| P/S | 1.96 | ||
| P/FCF | 6.14 | ||
| P/OCF | 5.65 | ||
| P/B | 5.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.97 |
EPS(TTM)5.63
EY14.2%
EPS(NY)5.23
Fwd EY13.2%
FCF(TTM)6.45
FCFY16.29%
OCF(TTM)7.01
OCFY17.69%
SpS20.26
BVpS7.83
TBVpS-9.98
PEG (NY)0.01
PEG (5Y)N/A
Graham Number31.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 17.49% | ||
| ROICexc | 22.99% | ||
| ROICexgc | 117.18% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.1 |
F-Score6
WACC8.3%
ROIC/WACC2.11
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year262.1%
EBIT Next 3Y50.55%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.
What is the valuation status of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.
What is the financial health of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.
How sustainable is the dividend of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 8 / 10 and the dividend payout ratio is 82.81%.